4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027016
CHIEF BUSINESS OFFICER acquired 94,789 shares (option exercise)
- CHIEF BUSINESS OFFICER acquired 8,126 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-01-15 | Option exercise | +91,406 | $0.30 | $27,422 | 281,962 | D |
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-04-18 | Option exercise | +3,383 | $6.11 | $20,670 | 285,345 | D |
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-06-29 | Conversion | +8,126 | 293,471 | D | ||
| Derivatives | |||||||
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-01-13 | Grant or award · Stock Option (right to buy) | +91,406 | 91,406 | D | ||
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-01-15 | Option exercise · Stock Option (right to buy) | −91,406 | 0 | D | ||
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-03-11 | Grant or award · Series B Preferred Stock | +19,763 | $5.06 | $100,001 | 19,763 | D |
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-03-17 | Grant or award · Stock Option (right to buy) | +162,410 | 162,410 | D | ||
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-03-17 | Grant or award · Stock Option (right to buy) | +69,604 | 69,604 | D | ||
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-04-18 | Option exercise · Stock Option (right to buy) | −3,383 | 159,027 | D | ||
| Gutry Phil CHIEF BUSINESS OFFICER | 2021-06-29 | Conversion · Series B Preferred Stock | −19,763 | 0 | D | ||
Loading xslF345X03/doc4.xml…